These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 30305547)
1. [Clinical application of mesenchymal stem cells for hematological diseases]. Taketani T Rinsho Ketsueki; 2018; 59(10):2362-2372. PubMed ID: 30305547 [TBL] [Abstract][Full Text] [Related]
2. The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease. Zhao L; Chen S; Yang P; Cao H; Li L Stem Cell Res Ther; 2019 Jun; 10(1):182. PubMed ID: 31227011 [TBL] [Abstract][Full Text] [Related]
3. [Mesenchymal stem cells for treatment of graft-versus-host disease]. Najima Y Rinsho Ketsueki; 2017; 58(12):2440-2449. PubMed ID: 29332881 [TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome. Ringdén O; Moll G; Gustafsson B; Sadeghi B Front Immunol; 2022; 13():839844. PubMed ID: 35371003 [TBL] [Abstract][Full Text] [Related]
5. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation. Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866 [TBL] [Abstract][Full Text] [Related]
6. [Current basic understanding and clinical application of mesenchymal stromal/stem cells]. Miura Y Rinsho Ketsueki; 2018; 59(10):1935-1941. PubMed ID: 30305494 [TBL] [Abstract][Full Text] [Related]
7. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice. Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958 [TBL] [Abstract][Full Text] [Related]
8. Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease. Ringden O; Baygan A; Remberger M; Gustafsson B; Winiarski J; Khoein B; Moll G; Klingspor L; Westgren M; Sadeghi B Stem Cells Transl Med; 2018 Apr; 7(4):325-331. PubMed ID: 29533533 [TBL] [Abstract][Full Text] [Related]
9. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Lazarus HM; Koc ON; Devine SM; Curtin P; Maziarz RT; Holland HK; Shpall EJ; McCarthy P; Atkinson K; Cooper BW; Gerson SL; Laughlin MJ; Loberiza FR; Moseley AB; Bacigalupo A Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293 [TBL] [Abstract][Full Text] [Related]
10. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568 [TBL] [Abstract][Full Text] [Related]
11. Co-transplantation of multipotent mesenchymal stromal cells in allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis. Kallekleiv M; Larun L; Bruserud Ø; Hatfield KJ Cytotherapy; 2016 Feb; 18(2):172-85. PubMed ID: 26794711 [TBL] [Abstract][Full Text] [Related]
12. The clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantation. Zhao K; Liu Q J Hematol Oncol; 2016 May; 9(1):46. PubMed ID: 27193054 [TBL] [Abstract][Full Text] [Related]
14. Human bone marrow mesenchymal stromal/stem cells: current clinical applications and potential for hematology. Miura Y Int J Hematol; 2016 Feb; 103(2):122-8. PubMed ID: 26692196 [TBL] [Abstract][Full Text] [Related]
15. A review of the application of mesenchymal stem cells in the field of hematopoietic stem cell transplantation. Lin T; Yang Y; Chen X Eur J Med Res; 2023 Aug; 28(1):268. PubMed ID: 37550742 [TBL] [Abstract][Full Text] [Related]
16. Mesenchymal Stromal Cell (MSC)-Derived Combination of CXCL5 and Anti-CCL24 Is Synergistic and Superior to MSC and Cyclosporine for the Treatment of Graft-versus-Host Disease. Fan X; Guo D; Cheung AMS; Poon ZY; Yap CS; Goh SE; Guo D; Li H; Bari S; Li S; Lim KH; Hwang WYK Biol Blood Marrow Transplant; 2018 Oct; 24(10):1971-1980. PubMed ID: 29883796 [TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stromal cells: a new tool against graft-versus-host disease? Baron F; Storb R Biol Blood Marrow Transplant; 2012 Jun; 18(6):822-40. PubMed ID: 21963621 [TBL] [Abstract][Full Text] [Related]
18. Clinical applications and biosafety of human adult mesenchymal stem cells. Mariani E; Facchini A Curr Pharm Des; 2012; 18(13):1821-45. PubMed ID: 22352750 [TBL] [Abstract][Full Text] [Related]
19. Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation? De Luca L; Trino S; Laurenzana I; Lamorte D; Caivano A; Del Vecchio L; Musto P Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28486431 [TBL] [Abstract][Full Text] [Related]
20. Heterogeneity in Studies of Mesenchymal Stromal Cells to Treat or Prevent Graft-versus-Host Disease: A Scoping Review of the Evidence. Rizk M; Monaghan M; Shorr R; Kekre N; Bredeson CN; Allan DS Biol Blood Marrow Transplant; 2016 Aug; 22(8):1416-1423. PubMed ID: 27130504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]